Chemical Works of Gedeon Richter (BUD:RICHTER) Owner Earnings per Share (TTM): 299.02 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUD:RICHTER Chemical Works of Gedeon Richter PLC BUD:RICHTER
100 GF Score
Price Ft13,360.00
GF Value Ft11,218.63
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Chemical Works of Gedeon Richter Owner Earnings per Share (TTM)?

Chemical Works of Gedeon Richter BUD:RICHTER +0.45% 100 Owner Earnings per Share (TTM) is 299.02 as of Jun. 2026. GuruFocus rates BUD:RICHTER with a GF Score™ of 100/100 and a GF Value™ of Ft11,218.63 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 466 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks worse than 72.1% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Chemical Works of Gedeon Richter's Owner Earnings per Share (TTM) ended in Jun. 2026 was Ft299.02. It's Price-to-Owner-Earnings ratio for today is 44.68.


The historical rank and industry rank for Chemical Works of Gedeon Richter's Owner Earnings per Share (TTM) or its related term are showing as below:

BUD:RICHTER' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.05   Med: 25.99   Max: 614.58
Current: 43.07


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Chemical Works of Gedeon Richter was 614.58. The lowest was 12.05. And the median was 25.99.


BUD:RICHTER's Price-to-Owner-Earnings is ranked worse than
72.1% of 466 companies
in the Drug Manufacturers industry
Industry Median: 23.425 vs BUD:RICHTER: 43.07

Chemical Works of Gedeon Richter's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was Ft209.00. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was Ft566.00. It's PE Ratio (TTM) ratio for today is 23.60.

Chemical Works of Gedeon Richter's EPS without NRI for the three months ended in Jun. 2026 was Ft253.86. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was Ft604.15. It's PE Ratio without NRI ratio for today is 22.11.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Chemical Works of Gedeon Richter Owner Earnings per Share (TTM) Related Terms


Chemical Works of Gedeon Richter Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Chemical Works of Gedeon Richter's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemical Works of Gedeon Richter Owner Earnings per Share (TTM) Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 433.77 605.90 374.58 266.23 211.47

Chemical Works of Gedeon Richter Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 343.07 215.24 211.47 317.89 299.02

BUD:RICHTER vs ZTS, UTHR, VTRS: Owner Earnings per Share (TTM) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter Price-to-Owner-Earnings vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's Price-to-Owner-Earnings falls into.


BUD:RICHTER
100GF Score
Chemical Works of Gedeon Richter PLC BUD:RICHTER
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemical Works of Gedeon Richter Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Chemical Works of Gedeon Richter's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 103,548
Depreciation, Depletion and Amortization 30,327
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 69,735
Change In Working Capital -9,427
Shares Outstanding (Diluted Average) 183

1. Start with "Net Income" from income statement. Chemical Works of Gedeon Richter's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was Ft103,548 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Chemical Works of Gedeon Richter's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Jun. 2026 was Ft30,327 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Chemical Works of Gedeon Richter's Change In Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 was Ft0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = Ft69,735 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Chemical Works of Gedeon Richter's 5-Year Average Maintenance Capital Expenditure = Ft69,735 Mil

5. "Change In Working Capital" is from cashflow statement. Chemical Works of Gedeon Richter's Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2026 was Ft-9,427 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Chemical Works of Gedeon Richter's Shares Outstanding (Diluted Average) for the months ended in Jun. 2026 was 182.972 Mil.

Chemical Works of Gedeon Richter's Onwer Earnings Per Share for Jun. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 103548 +30327+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-69735.36222229+-9427)/182.972
=299.02

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=13360.00/299.02
=44.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 299.02 mean?
Chemical Works of Gedeon Richter (BUD:RICHTER) has a Owner Earnings per Share (TTM) of 299.02 as of Jun. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Chemical Works of Gedeon Richter. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #336 out of 466 companies in the Drug Manufacturers industry, placing it in the top 72.1%.
Is Chemical Works of Gedeon Richter's Owner Earnings per Share (TTM) too high?
Chemical Works of Gedeon Richter's current Owner Earnings per Share (TTM) is 299.02. The Drug Manufacturers industry median Owner Earnings per Share (TTM) is 23.43. Chemical Works of Gedeon Richter's value of 299.02 is 1176.5% above this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #336 out of 466 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 100/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's Owner Earnings per Share (TTM) compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #336 out of 466 companies for Owner Earnings per Share (TTM). This places Chemical Works of Gedeon Richter in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 23.43. Chemical Works of Gedeon Richter's value of 299.02 is 1176.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Drug Manufacturers company?
The median Owner Earnings per Share (TTM) among Drug Manufacturers companies is 23.43, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current Owner Earnings per Share (TTM) of 299.02 is 1176.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Chemical Works of Gedeon Richter. For the Drug Manufacturers industry, the median Owner Earnings per Share (TTM) is 23.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current Owner Earnings per Share (TTM) is 299.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (BUD:RICHTER) is currently considered Modestly Overvalued. The stock's GF Value™ is Ft11,218.63, compared to a current price of Ft13,360.00 — trading 19.1% above its estimated fair value. The current Owner Earnings per Share (TTM) is 299.02 and 1176.5% above the Drug Manufacturers industry median of 23.43. Chemical Works of Gedeon Richter's overall GF Score™ is 100/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (BUD:RICHTER), the current Owner Earnings per Share (TTM) is 299.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemical Works of Gedeon Richter (BUD:RICHTER) Overvalued in 2026?

Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued. The current stock price of Ft13,360.00 is trading 19.1% above its estimated GF Value™ of Ft11,218.63. GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.

Key valuation signals for BUD:RICHTER:

  • Owner Earnings per Share (TTM): 299.02
  • GF Value™: Ft11,218.63 vs. price of Ft13,360.00 (19.1% above fair value)
  • GF Score™: 100/100 with 7 warning signs
  • Industry Position: 1176.5% above the Drug Manufacturers median (#336 of 466)

No single metric tells the full story. See the BUD:RICHTER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemical Works of Gedeon Richter Business Description

Address Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
100GF Score

Get the complete analysis for BUD:RICHTER

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft13,360.00
Price
Ft11,218.63
GF Value